Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

Clinical trial NCT05731544 · COMPLETED

Trial details

NCT number: NCT05731544
Sponsor: Biomea Fusion Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2022-08-17
Primary completion: 2024-11-18
Enrollment: 443

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.